'CAREDOSE Has Been Developed Keeping A Global Footprint In Mind'

With its proprietary technology and packaging system, CAREDOSE claims to bring down healthcare cost. In an conversation with Raelene Kambli, Gauri Angrish, Founder & CEO, CAREDOSE expounds on the her business model, innovative technology and her vision to provide cost-effective products.

You have integrated IOT mechanisms to discover actual time medicine adherence. Can you elaborate on the same. 

Medicine non-adherence is a silent epidemic that exists in more than 50 per cent of people on regular medication (World Health Organisation). What makes the problem worse is that more than 68 per cent of people do not communicate their nonadherence to their doctors or caregivers. This not only results in a worse disease progression but can also lead to wrong diagnosis. Additionally, since not adhering to one’s medication is a behavioural problem, we thought one way of ensuring 100 per cent adherence is by getting the patient's caregiver and/or doctor involved, by sending them alerts when the patient does not take his/her dose (negative adherence alerts), so that they can do something about it. Our smart dispenser uses IoT to remind patients about each dose and track their adherence, in real-time.

If patients do not take their doses on time, as prescribed by the doctor, then a "negative adherence alert" is automatically sent to the patient's chosen caregiver, in real-time. Once they receive an alert they can then ensure that the patient takes his/ her dose.

The Smart dispenser tracks the patient’s adherence patterns and each time the patient goes for his/her doctors appointment, the adherence data is provided to the doctor. Now the doctor knows exactly how the patients have or have not taken their medication as prescribed and this helps the doctor with easier diagnosis and gives the doctor more confidence in altering future prescriptions.